Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb).It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body.The first sign is most often vaginal bleeding not associated with a menstrual period.Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.

Approximately 40% of cases are related to obesity. Endometrial cancer is also associated with excessive estrogen exposure, high blood pressure and diabetes. Whereas taking estrogen alone increases the risk of endometrial cancer, taking both estrogen and a progestogen in combination, as in most birth control pills, decreases the risk.Between two and five percent of cases are related to genes inherited from the parents. Endometrial cancer is sometimes loosely referred to as "uterine cancer", although it is distinct from other forms of uterine cancer such as cervical cancer, uterine sarcoma, and trophoblastic disease.The most frequent type of endometrial cancer is endometrioid carcinoma, which accounts for more than 80% of cases. Endometrial cancer is commonly diagnosed by endometrial biopsy or by taking samples during a procedure known as dilation and curettage. A pap smear is not typically sufficient to show endometrial cancer.Regular screening in those at normal risk is not called for.

The leading treatment option for endometrial cancer is abdominal hysterectomy (the total removal by surgery of the uterus), together with removal of the Fallopian tubes and ovaries on both sides, called a bilateral salpingo-oophorectomy.

 In more advanced cases, radiation therapy, chemotherapy or hormone therapy may also be recommended. If the disease is diagnosed at an early stage, the outcome is favorable, and the overall five-year survival rate in the United States is greater than 80%.

Signs and Symptoms

Vaginal bleeding or spotting in women after menopause occurs in 90% of endometrial cancer. Bleeding is especially common with adenocarcinoma, occurring in two-thirds of all cases. Abnormal menstrual cycles or extremely long, heavy, or frequent episodes of bleeding in women before menopause may also be a sign of endometrial cancer.

Symptoms other than bleeding are not common. Other symptoms include thin white or clear vaginal discharge in postmenopausal women. More advanced disease shows more obvious symptoms or signs that can be detected on a physical examination. The uterus may become enlarged or the cancer may spread, causing lower abdominal pain or pelvic cramping. Painful sexual intercourse or painful or difficult urination are less common signs of endometrial cancer. The uterus may also fill with pus (pyometrea).Of women with these less common symptoms (vaginal discharge, pelvic pain, and pus), 10–15% have cancer.

Journal of Cancer Diagnosis is an open access peer-reviewed journal dealing with articles on different aspects of Physical exam, Laboratory tests, Imaging tests, Biopsy, Breast Cancer Diagnosis, Mammogram and breast ultrasound, Biopsy, Magnetic resonance imaging (MRI), Tumour biomarkers, Lung Cancer Diagnosis, Imaging tests, Sputum cytology, Tissue biopsy, Ovarian Cancer Diagnosis, Imaging tests, Blood test, Surgery, Tumour markers, tide specific antigen (TPS), Neuron specific enolase (NSE), Carcino Embryonic antigen (CEA), Liver Cancer Diagnosis, etc.

Our Journal follows Editorial Tracking System for quality in peer review process. Editorial Tracking is an online manuscript submission, review and tracking systems used by most of the best open access journals.

Submit manuscripts at: https://www.scholarscentral.org/submissions/cancer-diagnosis.html

Media Person

Nancy Ella
Journal Manager
Journal of Cancer Diagnosis

Email: cancerdiagn@emedsci.com